DIANA TORRES: Open Payments
NPI 1861077802 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 38 payments from 20 companies in 2025. Trend: 2023 $876 · 2024 $903 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $178 |
| Grifols USA, LLC | 5 | $140 |
| GENZYME CORPORATION | 3 | $71 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Insmed, Inc. | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| United Therapeutics Corporation | 2 | $45 |
| Aimmune Therapeutics, Inc. | 1 | $43 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Electromed, Inc. | 2 | $36 |
Products named: DUPIXENT, Prolastin-C Liquid, Arikayce, WINREVAIR, Tyvaso, ZENPEP, OFEV, SMARTVEST.
Industry payments across AR — which companies pay providers there.
